The Children's Research Institute
Pediatric Clinical Pharmacology Research Program
The Pediatric Clinical Pharmacology Research Program is funded by the National Institute of Child Health and Human Development (NICHD) Research Center in Pediatric Developmental Pharmacology (2011-2016 and 2016-2021) and is one of only four such centers across the nation. Each of these centers is specifically dedicated to support translational science in the area of pediatric clinical pharmacology. In addition, NICHD awarded Children’s National Health System a T32 grant for postdoctoral training in Pediatric Clinical Pharmacology, one of only five such T32s in the nation. This new T32 award allows collaborations with Johns Hopkins University School of Medicine, the U.S. Food and Drug Administration (FDA) and the School of Pharmacy at the University of Maryland. Over the years, the program has supported several investigators, including James M. Chamberlain, M.D., Natella Rakhmanina, M.D., Ph.D., Adelaide Robb, M.D., and Janelle Vaughns, M.D., in securing NIH and other external funding. Data from each of these studies promises to improve the safe and effective use of medicines for newborn infants, children and adolescents with HIV, seizures, psychiatric disorders, obesity and pain management.
Meet the Team
- Johannes Van den Anker, M.D., Ph.D.
- Janelle Vaughns, M.D.
- Elaine Williams, Ph.D.
- Natella Rakhmanina, M.D., Ph.D.
- Andrea Hahn, M.D.
- Shogo Miyagi, Pharm.D., Ph.D.
- Mae Liu, Pharm.D.